The Swiss biotech company Idorsia announced this week that it has received approval from the United States Food and Drug Administration (FDA) for its new drug that can help adult patients treat their insomnia. The sleeping pill, called Quviviq (daridorexant) is the first drug created by Idorsia that has received approval from the FDA, and, pending scheduling […]
The FDA grants approval for a new insomnia drug to improve sleep in adults Read More »




